7756-78-7 Usage
General Description
2-Methyl-2-(2-naphthyloxy)propanoic acid is a chemical compound with the formula C14H14O3. It is a derivative of propionic acid and contains a methyl group and a naphthyloxy group. 2-METHYL-2-(2-NAPHTHYLOXY)PROPANOIC ACID is primarily used as a pharmaceutical intermediate for the synthesis of pharmaceutical drugs, particularly those with anti-inflammatory or analgesic properties. It is known to have potential applications in the treatment of a variety of medical conditions, including pain, inflammation, and related disorders. The compound's chemical structure and properties make it a valuable reagent in the development and production of pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 7756-78-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,5 and 6 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7756-78:
(6*7)+(5*7)+(4*5)+(3*6)+(2*7)+(1*8)=137
137 % 10 = 7
So 7756-78-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H14O3/c1-14(2,13(15)16)17-12-8-7-10-5-3-4-6-11(10)9-12/h3-9H,1-2H3,(H,15,16)
7756-78-7Relevant articles and documents
SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1
-
Paragraph 00168; 00169; 00198; 00244, (2021/09/26)
The invention relates generally to novel EPAC1 activators, such as Formula (I) and (II) and the preparation thereof as well as the use of EPAC1 activators disclosed herein as to selectively activate EPAC1 in cells.
Synthesis and preliminary antihyperlipidaemic activities evaluation of andrographolide derivatives
Wang, Bin,Tang, Chunlei,Han, Yaodan,Guo, Ruzhou,Qian, Hai,Huang, Wenlong
experimental part, p. 293 - 298 (2012/07/30)
Recent studies indicated that andrographolide was a potential antihyperlipidaemic therapeutic agent. In the paper, the synthesis of a series of andrographolide derivatives was described and their antihyperlipidaemic activities were evaluated in vivo. As compared with TG, TC, HDL-C and LDL-C concentrations, some of the derivatives exhibited better antihyperlipidaemic effects than positive control atromide. Therein, compound 6i, which was the most potent compound, could serve as a new lead for further development of antihyperlipidaemic agents.
